FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

851841000168103: bicalutamide 50 mg tablet [28 tablets] (&) inert substance diluent [1 syringe] (&) leuprorelin acetate 22.5 mg modified release injection [1 x 22.5 mg syringe], 1 pack (medicinal product pack)


Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
1731221000168113 bicalutamide 50 mg tablet [28 tablets] (&) inert substance diluent [1 syringe] (&) leuprorelin acetate 22.5 mg modified release injection [1 x 22.5 mg syringe], 1 pack (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
1731231000168111 leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack en Synonym Active Case sensitive Australian Medicines Terminology module


4 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack Is a bicalutamide 50 mg tablet, 28 tablets (medicinal product pack) true Inferred relationship Some
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack Is a leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack true Inferred relationship Some
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack has MPUU bicalutamide 50 mg tablet true Inferred relationship Some 2
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack has MPUU leuprorelin acetate 22.5 mg modified release injection, syringe true Inferred relationship Some 1
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack has MPUU inert substance diluent, syringe true Inferred relationship Some 3
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack has component pack bicalutamide 50 mg tablet, 28 tablets (medicinal product pack) true Inferred relationship Some
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack has component pack leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 28 x Bicalutamide (MPL) tablets), 1 pack Is a True leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack Inferred relationship Some
Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 28 x Bicalutamide (Tolmar) tablets), 1 pack Is a True leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [28], 1 pack Inferred relationship Some

Reference Sets

List of Medicines for Brand Consideration reference set

Medicinal product pack reference set

Back to Start